TTrialPathMatch Me to Trials
← Back to trials
RecruitingAortic Arch DissectionAortic Arch Aneurysm

GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study

Eligible age

18+ yrs

Accepts

All genders

Locations

12 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.

Sponsor: W.L.Gore & Associates

You may qualify if…

  • ✓ 1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements.
  • ✓ 2. Patient has been or is intended to be treated with the TBE Device in Zone 0 or Zone 1.
  • ✓ 3. Patient is age ≥ 18 years at time of informed consent signature.

You may not qualify if…

  • ✕ 1. Patient who is, at the time of consent, unlikely to be available for defined follow-up visits.
  • ✕ 2. Patient with exclusion criteria required by local law.
  • ✕ 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or investigational device study within 12 months of study enrollment. Subjects cannot be enrolled in another Gore study.

Where it's recruiting

Arizona

Scottsdale

California

Los Angeles · Sacramento

Connecticut

Hartford

District of Columbia

Washington D.C.

Florida

Gainesville · Lakeland · Tampa

Maryland

Baltimore

North Carolina

Chapel Hill · Durham

Pennsylvania

Philadelphia · Pittsburgh

Texas

Houston · Plano

Utah

Murray

Washington

Seattle

Wisconsin

Madison · Milwaukee

Source: ClinicalTrials.gov · NCT07166133 · last updated 2026-09-25

GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study · TrialPath